Skip Navigation

Miami Cancer Institute

Location

Miami Cancer Institute
8900 North Kendall Drive, Suite 3R200
Miami, FL 33176
Direct phone: (786) 527-8400

Total transplants by cell source

From January 1, 2021 to December 31st, 2022
  • Marrow: 0
  • PBSC: 43
  • Cord Blood: 0
  • Autologous (PBSC or Marrow): 56
Performs adult transplants

Overview

Miami Cancer Institute is part of the Baptist Health South Florida network, one of the largest hospital networks in South Florida. The Blood and Marrow Transplant program of Miami Cancer Institute treats hematologic malignancies in both inpatient and outpatient state of the art facilities. Our unique approach using CD34 selected products offers a reduced risk of Graft versus Host disease post-transplant. Our program offers a holistic approach to transplant with our cancer support services including nutrition, psychological, social work, rehabilitation, and survivorship. Miami Cancer Institute began performing allogeneic transplants in July 2019 and became a member of the NMDP/Be the Match network in June 2020.

This center has been performing allogeneic transplants since 2019 and has been an NMDP/Be The Match transplant center since June 2020.

Attending physicians

Adult - Nadia Bambace, Lyle Feinstein, Guenther Koehne, Yuliya Linhares, George Nahas, Ariel Perez Perez, Marco Ruiz

Transplants performed

Marrow/PBSC only

Cord blood transplants performed on

Adult only

Other programs and services

This institute offers CAR T Cell Therapy as well as Bloodless Autologous Stem Cell Transplants.

The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected, as Florida’s only member of the Memorial Sloan Kettering Cancer Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at Memorial Sloan Kettering Cancer Institute.

About the center

Overview

Miami Cancer Institute is part of the Baptist Health South Florida network, one of the largest hospital networks in South Florida. The Blood and Marrow Transplant program of Miami Cancer Institute treats hematologic malignancies in both inpatient and outpatient state of the art facilities. Our unique approach using CD34 selected products offers a reduced risk of Graft versus Host disease post-transplant. Our program offers a holistic approach to transplant with our cancer support services including nutrition, psychological, social work, rehabilitation, and survivorship. Miami Cancer Institute began performing allogeneic transplants in July 2019 and became a member of the NMDP/Be the Match network in June 2020.

This center has been performing allogeneic transplants since 2019 and has been an NMDP/Be The Match transplant center since June 2020.

Attending physicians

Adult - Nadia Bambace, Lyle Feinstein, Guenther Koehne, Yuliya Linhares, George Nahas, Ariel Perez Perez, Marco Ruiz

Transplants performed

Marrow/PBSC only

Cord blood transplants performed on

Adult only

Other programs and services

This institute offers CAR T Cell Therapy as well as Bloodless Autologous Stem Cell Transplants.

The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected, as Florida’s only member of the Memorial Sloan Kettering Cancer Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at Memorial Sloan Kettering Cancer Institute.

Overall center survival


Patient survival information for this center

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

  1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2019, 2020, 2021, and
  2. Who had their transplant at a U.S. transplant center, and
  3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 53 patients.

The actual 1-year survival of these patients is 73.6%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 62.3% and 85.0%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

Total transplants

Total transplants


99

Transplants reported (From January 1, 2021 to December 31st, 2022 as reported by the centers)

Marrow PBSC Cord blood Total
Allogeneic
Related donor 0 17 0 17
Unrelated donor 0 26 0 26
Total allogeneic 0 43 0 43
Autologous
Both marrow & PBSC
56
-- 56
Total combined
99 0 99

Transplants by disease

All diseases

Number of transplants by age reported from January 1, 2021 to December 31st, 2022 (includes marrow, PBSC and cord blood)

0-18 19-44 45-64 65+ Total
Related 0 2 9 6 17
Unrelated 0 3 14 9 26
Autologous 0 4 24 28 56
Total 0 9 47 43 99

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.

Centers are not required to report autologous transplants so the numbers might be incomplete.

More information about transplants for this disease can be found:

Additional information

Transplant center resources

Transplant center coordinator:
Lisandra Rodriguez Perez
786-527-8489
Email: lisandra.rodriguezperez@baptisthealth.net

If you have questions about costs and financial services at this center, please call the transplant center's direct phone number.

NMDP patient navigators

Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.

Inside the United States: 1 (888) 999-6743

Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)

Email: patientinfo@nmdp.org

Survivorship program


No survivorship program information is available. Contact the center for information about post-transplant care.